Deal Between GSK, Brazil To Strengthen Country's Pharmaceutical R&D

[NewsWhore]

GlaxoSmithKline (GSK) Chief Executive Andrew Witty on Friday announced Brazil has agreed to buy roughly $2.2 billion of the company's vaccine for pneumococcal disease, Synflorix, for a period of at le...

More... (http://story.brazilsun.com/index.php/ct/9/cid/24437442923341f1/id/28305616/)